Vanda Pharmaceuticals | VNDA - Ebitda





Ebitda Cambiamento Data
Acadia Pharmaceuticals USD 20.31M 15.44M 2025-12
Agios Pharmaceuticals USD -120.31M 4.82M 2025-12
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD 57.17M 7.03M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Halozyme Therapeutics USD 219.57M 197.66M 2026-03
Heron Therapeutics USD -3.88M 5.63M 2024-09
Insmed USD -148.3M 165.88M 2026-03
J&J USD 7.19B 2.32B 2025-12
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
Ligand Pharmaceuticals USD 66.78M 83.54M 2025-12
Merck USD 6.3B 2.09B 2025-12
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Moderna USD -790M 582M 2025-12
Novartis USD 5.41B 431M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
PTC Therapeutics USD -70.99M 91.62M 2025-12
Puma Biotechnology USD 729K 11.36M 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
Takeda JPY 150.25B 297.88B 2026-03
Teva Pharmaceutical Industries USD 1.06B 582M 2026-03
Ultragenyx Pharmaceutical USD -99.43M 57.35M 2025-12
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12
Veracyte USD 42.8M 488K 2026-03